Company overview
Basic information
Company name
Švaros atspindys, MB
Company code
306234479
Registered address
Palanga, J. Janonio g. 24, LT-00133
Registration date
2023-01-27
Company age: 3 y. 9 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
General cleaning of buildings
Ownership form
Private without foreign capital
MB "Švaros atspindys"
Company code: 306234479
Address: Palanga, J. Janonio g. 24, LT-00133
Description
This description was generated by artificial intelligence.
Švaros atspindys, MB (company code 306234479) is an operational private small partnership registered on 27 January 2023. The company belongs to the national private non-financial companies sector and is organised under a CEO-only governance structure. It is classified as a micro company and is privately owned, with more than 50% of the authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. The company is based in Palanga, at J. Janonio g. 24, LT-00133, Palangos m. municipality, Klaipeda County. Its core activity is EVRK O.81.21.00, General cleaning of buildings. Financially, the company reported revenue of EUR 11.9K in 2025, down from EUR 23.6K in 2024, while net profit amounted to EUR 5.4K and the profit margin was 45.0%. Over the longer term, revenue increased strongly compared with 2023, when the business operated for 338 days and recorded EUR 3.1K in revenue. At the end of 2025, equity stood at EUR 10.2K, total assets at EUR 10.9K, and liabilities at EUR 721. The balance sheet remained largely equity-financed.
Download a detailed company report
Make confident decisions with all the information about Švaros atspindys, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.